Author

Courtney H. Bouk

Observed names: Courtney Bouk, Courtney H Bouk

Institutions: Frederick National Laboratory for Cancer Research, Leidos Biomedical Research Inc. (United States)

Observed institutions: Frederick National Laboratory for Cancer Research, Leidos Biomedical Research Inc. (United States)

OpenAlex ID: A5083521289

Analytical Validation of the Next-Generation Sequencing Assay for a Nationwide Signal-Finding Clinical Trial

2017 · Chih-Jian Lih, Robin D. Harrington, et al. · Journal of Molecular Diagnostics · 159

Analytical Validation and Application of a Targeted Next-Generation Sequencing Mutation-Detection Assay for Use in Treatment Assignment in the NCI-MPACT Trial

2015 · Chih-Jian Lih, David J. Sims, et al. · Journal of Molecular Diagnostics · 42

Plasmid-Based Materials as Multiplex Quality Controls and Calibrators for Clinical Next-Generation Sequencing Assays

2016 · David J. Sims, Robin D. Harrington, et al. · Journal of Molecular Diagnostics · 29

Feasibility of molecular profiling based assignment of cancer treatment (MPACT): A randomized NCI precision medicine study.

2016 · Alice P. Chen, Mickey Williams, et al. · Journal of Clinical Oncology · 8

Use of Biosynthetic Controls as Performance Standards for Next-Generation Sequencing Assays of Somatic Tumors: A Multilaboratory Study

2017 · Francine B De Abreu, Jason D Peterson, et al. · The Journal of Applied Laboratory Medicine

Works count: 5

Citation count: 238

H-index: 4

I10-index: 3